Baidu
map

黑龙江严惩医药购销商业贿赂

2018-11-29 董宇翔 衣晓峰 健康报网

黑龙江省卫生健康委近日出台《医疗卫生机构医药购销领域商业贿赂处理办法(试行)》。今后,该省医疗卫生机构工作人员发生医药购销领域商业贿赂行为,涉嫌犯罪的,将移送有关机关处理。

黑龙江省卫生健康委近日出台《医疗卫生机构医药购销领域商业贿赂处理办法(试行)》。今后,该省医疗卫生机构工作人员发生医药购销领域商业贿赂行为,涉嫌犯罪的,将移送有关机关处理。

《办法》规定,禁止医疗卫生机构及其工作人员利用职务之便,收受、索取商业贿赂,或假借特定关系人名义收受、索取商业贿赂。《办法》所称医药购销领域商业贿赂包括:收受、索取医药生产经营企业及其代理人以各种名义所送现金、礼卡、购物券、贵重物品和支付凭证等财物的行为;接受医药生产经营企业及其代理人提供的国内外各种名义旅游、考察、娱乐性消费及变相学术会议等行为;收受、索取医药生产经营企业及其代理人提供的转诊患者介绍费、临床促销费、开单(药品、耗材等)提成费、推介费以及各种形式财物的行为;为医药生产经营企业及其代理人进行处方统计,提供医药产品使用情况及数量,收受、索取财物或者其他利益的行为;涉及医药购销领域的其他收受、索取贿赂行为。

《办法》规定,医疗卫生机构应当加强对本单位医药购销领域商业贿赂的预防与控制工作。加强反商业贿赂政策宣传,在单位醒目位置、门户网站等公布本级和上级卫生行政主管部门举报电话、举报信箱或其他举报途径,方便社会各界监督、举报。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1908007, encodeId=7297190800e77, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Jan 25 23:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647610, encodeId=2d92164e610b6, content=<a href='/topic/show?id=d41d3538023' target=_blank style='color:#2F92EE;'>#医药购销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35380, encryptionId=d41d3538023, topicName=医药购销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb023457929, createdName=xuqianhua, createdTime=Thu Jan 24 11:00:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006627, encodeId=818a200662e89, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sat May 11 11:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771787, encodeId=f8191e7178762, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Wed Dec 12 22:00:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409728, encodeId=35a51409e2883, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 01 06:00:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1908007, encodeId=7297190800e77, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Jan 25 23:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647610, encodeId=2d92164e610b6, content=<a href='/topic/show?id=d41d3538023' target=_blank style='color:#2F92EE;'>#医药购销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35380, encryptionId=d41d3538023, topicName=医药购销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb023457929, createdName=xuqianhua, createdTime=Thu Jan 24 11:00:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006627, encodeId=818a200662e89, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sat May 11 11:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771787, encodeId=f8191e7178762, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Wed Dec 12 22:00:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409728, encodeId=35a51409e2883, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 01 06:00:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1908007, encodeId=7297190800e77, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Jan 25 23:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647610, encodeId=2d92164e610b6, content=<a href='/topic/show?id=d41d3538023' target=_blank style='color:#2F92EE;'>#医药购销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35380, encryptionId=d41d3538023, topicName=医药购销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb023457929, createdName=xuqianhua, createdTime=Thu Jan 24 11:00:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006627, encodeId=818a200662e89, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sat May 11 11:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771787, encodeId=f8191e7178762, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Wed Dec 12 22:00:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409728, encodeId=35a51409e2883, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 01 06:00:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1908007, encodeId=7297190800e77, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Jan 25 23:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647610, encodeId=2d92164e610b6, content=<a href='/topic/show?id=d41d3538023' target=_blank style='color:#2F92EE;'>#医药购销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35380, encryptionId=d41d3538023, topicName=医药购销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb023457929, createdName=xuqianhua, createdTime=Thu Jan 24 11:00:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006627, encodeId=818a200662e89, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sat May 11 11:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771787, encodeId=f8191e7178762, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Wed Dec 12 22:00:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409728, encodeId=35a51409e2883, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 01 06:00:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1908007, encodeId=7297190800e77, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Fri Jan 25 23:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647610, encodeId=2d92164e610b6, content=<a href='/topic/show?id=d41d3538023' target=_blank style='color:#2F92EE;'>#医药购销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35380, encryptionId=d41d3538023, topicName=医药购销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb023457929, createdName=xuqianhua, createdTime=Thu Jan 24 11:00:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006627, encodeId=818a200662e89, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sat May 11 11:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771787, encodeId=f8191e7178762, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Wed Dec 12 22:00:00 CST 2018, time=2018-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409728, encodeId=35a51409e2883, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 01 06:00:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
    2018-12-01 cathymary

相关资讯

黑龙江一九月龄女婴先天性过敏全身溃烂,连闯三道生命关获救

因为先天性过敏性体质,9个月的女孩小佳全身溃烂,经过黑龙江哈尔滨市儿童医院全力抢救一个月,目前孩子已达到出院标准,不日将离院回家休养。第一关:深静脉注射全身溃烂找不到血管7月24日,记者在哈尔滨市儿童医院重症科见到了正在接受治疗的小佳,孩子除身上还有一些斑痕外,与其他孩子并无区别。在医生留存的图片档案上记者看到,这个小婴儿全身起了上百个血疱,皮肤几乎没有一块完整的。6月24日,小佳被送到了儿童医

又有7个药通过一致性评价,大洗牌来了

据业内人士透露,国家医保局牵头的11城市联合集中带量采购方案,马上就要出台了。而这个采购方案,就是主要针对目前的通过一致性评价药品的。

“院长不得兼任科主任”新规来了 院长们怎么看?

近日,黑龙江省印发《黑龙江省建立现代医院管理制度实施方案》(下称方案)。方案指出,到2020年,基本形成维护公益性、调动积极性、保障可持续的公立医院运行新机制。值得注意的是,方案中规定公立医院主要领导应当专职从事医院管理,确保主要精力和时间用于管理工作,不得兼任业务科室负责人。一直以来,很多院领导均有兼任科室主任的经历,有的是出于临床情结,有的认为贴近一线更利于熟悉情况改善管理,或兼而有之。黑龙

黑龙江出新规:患者入院要与医院签订不收送“红包”协议

有些患者总是“变着法儿”的给医生塞红包,以后别坑医生了!收红包可能让他们被开除!“红包”将上缴到违纪专用账户日前,我省发布《黑龙江省医务人员收受“红包”处理暂行规定》,患者入院后要与医院签订《医患双方不收和不送“红包”协议书》,接到医务人员上交“红包”后,医疗机构相关责任部门要依据职责将其存储到“红包”专用账户,最终红包将上缴至纪委违纪专用账户。今年为“红包”、回扣专项整治年下步,将在全省范围内

黑龙江:启动基层卫技人员健康扶贫培训项目

从今年起,黑龙江省将在28个贫困县(市)启动健康扶贫培训项目,并在2019年在全省范围全面铺开;争取到2020年,全省90%以上基层卫生技术人员接受“健康扶贫”培训。

黑龙江用互联网医疗健康惠民

今年年底前,全省二级以上医院要全部实现互联网医疗健康惠民服务,其中三级甲等医院要实现深度惠民服务。

Baidu
map
Baidu
map
Baidu
map